Search Results

Oliver Hartley Oliver Hartley is VP for Drug Discovery at Orion Biotechnology . Oliver Hartley on the web LinkedIn Orion Biotechnology Dr.

Timo De Groof studied Biochemistry and Biotechnology at the University of Ghent where he graduated in During his master's studies, he specialized in Biomedical Biotechnology and Structural Biology/Biochemistry

following three years on the editorial teams of Nature Structural and Molecular Biology and Nature Biotechnology

Last summer, Julia worked at as the first-ever summer intern at Septerna, the GPCR-based biotechnology

She received her undergraduate degree in Biotechnology from KIIT University in India.

Kathryn E Livingston is currently a Product Manager at Gator Bio , a biotechnology company providing

of Heptares Therapeutics , now called Sosei Heptares , a GPCR-focused drug discovery and development biotechnology

Andrew is translating fundamental findings to commercial products is Keltic Pharma Therapeutics Ltd , a biotechnology

Her work is currently funded by Biotechnology and Biological Sciences Research Council (BBSRC), Diabetes

He earned his master's degree in biotechnology from Jawaharlal Nehru University in India and it was during

Sexton is also a co-founder of the San Francisco-based biotechnology company Septerna Inc . Dr.

Ralf Jockers Ralf Jockers studied in Cologne and received a Ph.D. in biotechnology and biochemistry from

., a UK-based biotechnology company (2009-2012), where he was responsible all of the company’s discovery

oncology research led me to pursue a BSc in Biology & Economics from Carleton University, and an MSc in Biotechnology In my role at Orion Biotechnology, I work at the intersection of science and business, which includes

based in South Korea, has recently been named President of GPCR Therapeutics, USA, a newly incorporated Biotechnology

Her work is currently funded by Biotechnology and Biological Sciences Research Council (BBSRC), Diabetes

She received her undergraduate degree in Biotechnology from KIIT University in India.

News—your go-to spot for the latest, real-time updates in the world of GPCR research, pharmacology, and biotechnology

competitive, charitable and commercial sources, as well as being academic co-founder of three GPCR-focussed biotechnology

competitive, charitable and commercial sources, as well as being academic co-founder of three GPCR-focussed biotechnology

competitive, charitable and commercial sources, as well as being academic co-founder of three GPCR-focussed biotechnology